Compared to the control group, serum levels of HSPA6 and NOTCH3 were significantly elevated in the CRC tumor group, whereas GPD1L, PKP2, and SMAD9 exhibited a marked decrease (Fig. 8E). This evidence concerns the gene HSPA6 and colorectal carcinoma.